Landin Boring focuses his practice on patent acquisition and counseling in the Health and Life Sciences industry area. He prosecutes patents for clients in the U.S. and abroad, and provides patentability, patent validity, infringement, and freedom-to-operate counseling to assist clients in business planning. Dr. Boring has experience in a number of technical and legal areas, including molecular biology, immunology, diagnostics, microarrays, biomarkers, and medical devices. Most recently he worked as an associate with a Seattle-based IP firm. Prior to practicing law, Dr. Boring was a post-doctoral fellow with Bristol-Myers Squibb Pharmaceutical Research Institute in Seattle, a staff research investigator with the Gladstone Institutes in San Francisco, and a molecular biology group leader at Xenogen Biosciences in Cranbury, New Jersey. Dr. Boring was selected for inclusion in a 2010 Washington "Rising Star" by SuperLawyers magazine. Professional & Community Activities American Intellectual Property Law Association, Member Industries Health & Life Sciences; Medical & Surgical Devices Publications 01 September 2008, Patents Protecting Wine Growers
Source: King County Bar Association Bulletin, Articles 01 August 2005, Can a Method Claim be Infringed if All Steps of the Patented Process are Not Used Within the United States?
Source: CASRIP Newsletter, Articles 02 September 2004, Non-invasive imaging of GFAP expression after neuronal damage in mice
Source: Neuroscience Letters, Articles 01 January 2004, Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer
Source: American Association for Cancer Research Journals, Articles 15 June 2002, Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion
Source: Journal of Neuroscience Research, Articles 21 May 2002, Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen
Source: Cytokine, Articles |